HealthLynked Corp

Name: HealthLynked Corp standardized financial statements, quarterly
Creator: Listed

HLYKOTCCIK 1680139HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$249.8k, Q2 FY2026

Operating income−$538.8k, Q2 FY2026

Net income−$819.7k, Q2 FY2026

HealthLynked Corp, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	1,333	931	1,004	795	590	619	774	592	389	310	423	250
Cost of revenue	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Gross profit	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Selling, general and administrative	$k	768	918	999	861	632	546	629	452	501	454	847	517
Operating income	$k	(1,185)	(1,112)	(1,178)	(1,079)	(1,671)	(749)	(617)	(435)	(530)	(531)	(701)	(539)
Interest expense	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Net income	$k	(175)	(1,286)	(1,388)	(1,540)	(1,973)	(1,230)	(1,051)	(701)	(852)	(676)	(1,621)	(820)
Diluted EPS	$ per share	0.00	not reported	0.00	(0.01)	(0.70)	not reported	(0.37)	(0.25)	(0.30)	not reported	(0.56)	(0.28)
Basic EPS	$ per share	0.00	not reported	0.00	(0.01)	(0.70)	not reported	(0.37)	(0.25)	(0.30)	not reported	(0.56)	(0.28)

Balance sheet

Cash and equivalents$12.8k, Q2 FY2026

Shareholders' equity−$7.8m, Q2 FY2026

HealthLynked Corp, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$k	51.3	247	23.5	173	15.0	76.2	22.3	20.2	10.9	37.1	24.0	12.8
Current assets	$k	2,202	656	1,896	2,006	1,824	1,641	1,568	1,559	1,543	1,552	1,539	1,545
Total assets	$k	5,689	4,280	3,891	3,860	2,758	2,223	2,057	1,848	1,765	1,702	1,626	1,593
Current liabilities	$k	3,360	2,412	2,695	3,396	3,807	4,690	5,600	6,126	6,744	7,013	8,198	8,896
Total liabilities	$k	4,128	3,475	3,669	4,284	4,691	5,352	6,195	6,601	7,198	7,464	8,648	9,346
Long-term debt	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$k	1,561	805	221	(425)	(1,933)	(3,129)	(4,137)	(4,752)	(5,433)	(5,762)	(7,022)	(7,753)

Cash flow

Operating cash flow−$350.1k, Q2 FY2026

Capital expenditure$0, Q4 FY2024

HealthLynked Corp, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,249)	(1,192)	(855)	(859)	(1,037)	(744)	(433)	(418)	(444)	(419)	(222)	(350)
Capital expenditure	$k	not reported	0.0	2.6	0.0	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported
Share repurchases	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)2.94m, Q2 FY2026

HealthLynked Corp, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	243	257	260	266	280	282	2.8	2.8	2.8	2.8	2.9	2.9

Shares outstanding: 2.95m at Aug 14, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.